Asset Management Advisors LLC purchased a new stake in Henry Schein, Inc. (NASDAQ:HSIC) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 37,705 shares of the company’s stock, valued at approximately $2,739,000. Henry Schein comprises 2.3% of Asset Management Advisors LLC’s investment portfolio, making the stock its 19th largest position.
Other institutional investors and hedge funds have also modified their holdings of the company. Commerce Bank raised its position in shares of Henry Schein by 5.5% during the 1st quarter. Commerce Bank now owns 14,473 shares of the company’s stock worth $973,000 after purchasing an additional 760 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund raised its position in shares of Henry Schein by 1.8% during the 2nd quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 46,794 shares of the company’s stock worth $3,399,000 after purchasing an additional 846 shares during the period. BB&T Securities LLC increased its position in Henry Schein by 26.8% in the 1st quarter. BB&T Securities LLC now owns 4,676 shares of the company’s stock valued at $314,000 after acquiring an additional 988 shares during the period. Gabelli Funds LLC increased its position in Henry Schein by 0.3% in the 1st quarter. Gabelli Funds LLC now owns 332,300 shares of the company’s stock valued at $22,334,000 after acquiring an additional 1,100 shares during the period. Finally, Dupont Capital Management Corp increased its position in Henry Schein by 4.7% in the 1st quarter. Dupont Capital Management Corp now owns 25,620 shares of the company’s stock valued at $1,722,000 after acquiring an additional 1,148 shares during the period. 96.65% of the stock is owned by hedge funds and other institutional investors.
Several analysts recently commented on HSIC shares. Zacks Investment Research cut Henry Schein from a “buy” rating to a “hold” rating in a research report on Thursday, August 2nd. BidaskClub upgraded Henry Schein from a “hold” rating to a “buy” rating in a research report on Wednesday, June 13th. Leerink Swann set a $100.00 price target on Henry Schein and gave the company a “buy” rating in a research note on Tuesday, August 7th. Barrington Research decreased their price target on Henry Schein to $88.00 and set an “outperform” rating for the company in a research note on Thursday, May 10th. Finally, TheStreet raised Henry Schein from a “c” rating to a “b-” rating in a research note on Monday, May 14th. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and nine have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $84.11.
Shares of Henry Schein stock traded up $0.68 during midday trading on Friday, hitting $77.68. The company’s stock had a trading volume of 1,388,000 shares, compared to its average volume of 1,620,635. The stock has a market cap of $12.36 billion, a PE ratio of 21.58, a price-to-earnings-growth ratio of 2.31 and a beta of 1.00. The company has a quick ratio of 0.68, a current ratio of 1.29 and a debt-to-equity ratio of 0.34. Henry Schein, Inc. has a 1-year low of $62.56 and a 1-year high of $89.34.
Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Monday, August 6th. The company reported $1.04 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.01 by $0.03. Henry Schein had a return on equity of 20.40% and a net margin of 3.15%. The business had revenue of $3.33 billion during the quarter, compared to analyst estimates of $3.31 billion. During the same period last year, the company earned $0.88 earnings per share. Henry Schein’s quarterly revenue was up 8.7% compared to the same quarter last year. analysts expect that Henry Schein, Inc. will post 4.11 EPS for the current fiscal year.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading: Investing in Growth Stocks
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.